Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

Table 1

Analysis of metastases during vaccination.

Abdomen	Week 0	Week 15	Week 22	Week 26
Met A (Liver)	20	20	15	10
Met B (l.n.)	22	17	8	8
Met C (l.n.)	22	25	7	9
Met D (l.n.)	25	25	7	6
Met E (l.n.)	12	7	0	0
Sum	101	94	37	33

Met: metastasis, l.n.: lung node.